Tamargo J.
Selecting emergency therapy for patients with pre-eclampsia
Expert Opin Pharmacother. 2020 Mar 5:1-4. doi: 10.1080/14656566.2020.1727444. PMID: 32133877

González-Juanatey JR, Tamargo J, Torres F, Weisser B, Oudovenko N.
Pharmacodynamic study of the cardiovascular polypill. Is there any interaction among the monocomponents?
Rev Esp Cardiol (Engl Ed). 2020 Jan 23. pii: S1885-5857(19)30415-3. doi: 10.1016/j.rec.2019.11.008. PMID: 31983653. [Epub ahead of print]

Ruilope LM, Tamargo J, Ruiz-Hurtado G.
Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs
Eur Heart J. 2020 Jun 7;41(22):2067-2069. doi: 10.1093/eurheartj/ehaa487. PMID: 32498078

Tamargo J.
Treatment of Coronavirus Disease 2019: Shooting in the Dark
Eur Cardiol. 2020 Aug 10;15:e59. doi: 10.15420/ecr.2020.21. eCollection 2020 Feb. PMID: 32944088

Savarese G, Reiner MF, Uijl A, D Amario D, Agewall S, Atar D, Baumgartner I, Borghi C, De Carlo M, Drexel H, Kaski JC, Kjeldsen KP, Kucher N, Lund LH, Niessner A, Semb AG, Schmidt TA, Sulzgruber P, Tamargo J, Vitale C, Wassmann S, Aboyans V, Lewis BS.
Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease: Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases
Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):86-93. doi: 10.1093/ehjcvp/pvz036. PMID: 31392312

Tamargo J.
After a long time, the new ESC Guidelines for the management of patients with supraventricular tachycardia are here
Eur Heart J Cardiovasc Pharmacother. 2020 Jan 1;6(1):3-5. doi: 10.1093/ehjcvp/pvz068. PMID: 31800023

Kaski JC, Tamargo J, Savarese G.
Cardiovascular pharmacotherapy in older people: challenges posed by cardiovascular drug prescription in the elderly.
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 1;6(5):277-279. doi: 10.1093/ehjcvp/pvaa090. PMID: 32687147

El Hadidi S, Rosano G, Tamargo J, Agewall S, Drexel H, Kaski JC, Niessner A, Lewis BS, Coats AJS.
Potentially Inappropriate Prescriptions in Heart Failure with Reduced Ejection Fraction (PIP-HFrEF)
Eur Heart J Cardiovasc Pharmacother. 2020 Sep 17:pvaa108. doi: 10.1093/ehjcvp/pvaa108. Online ahead of print. PMID: 32941594

Refoyo E, Troya J, Trigo E, Guzmán-Martinez G, Valbuena-López S, Caro-Codón J, Rosillo S, Moreno-Yanguela M, Tamargo J, Arribas JR, Acquatella H, Lopez-Sendon J.
Comparison of Noninvasive Cardiac Test Strategies for Newly Diagnosed Chagas Disease in a Non-Endemic Zone
Am J Trop Med Hyg. 2020 Jul 20. doi: 10.4269/ajtmh.20-0389. Online ahead of print. PMID: 32700660

Naccarelli GV, Bhatt DL, Camm AJ, Le Heuzey JY, Lombardi F, Tamargo J, Martinez JM, Naditch-Brûlé L; ARTEMIS AF Investigators.
Evaluation of the Switch From Amiodarone to Dronedarone in Patients With Atrial Fibrillation: Results of the ARTEMIS AF Studies.
J Cardiovasc Pharmacol Ther. 2020 Sep;25(5):425-437. doi: 10.1177/1074248420926874. Epub 2020 Jun 5. PMID: 32500725

Tinaquero D, Crespo-García T, Utrilla RG, Nieto-Marín P, González-Guerra A, Rubio-Alarcón M, Cámara-Checa A, Dago M, Matamoros M, Pérez-Hernández M, Tamargo M, Cebrián J, Jalife J, Tamargo J, Bernal JA, Caballero R, Delpón E; ITACA Investigators.
The p.P888L SAP97 polymorphism increases the transient outward current (Ito,f) and abbreviates the action potential duration and the QT interval.
Sci Rep. 2020 Jul 1;10(1):10707. doi: 10.1038/s41598-020-67109-z. PMID: 32612162

Fontenla A, López-Gil M, Tamargo J, Matía-Frances R, Salgado-Aranda R, Rey-Blas JR, Miracle-Blanco A, Mejía-Martínez E, Pastor-Fuentes A, Toquero-Ramos J, Arias MA, Montilla M, Gómez de la Cámara A, Arribas F, en representación de los investigadores BRAKE-AF.
Ivabradine for chronic heart rate control in persistent atrial fibrillation. Design of the BRAKE-AF project
Rev Esp Cardiol (Engl Ed). 2020 May;73(5):368-375. doi: 10.1016/j.rec.2019.09.004. Epub 2019 Oct 17. PMID: 31631048

Fontenla A, Tamargo Menéndez J, López Gil M, Arribas F.
[Do we have a new drug for heart rate control in patients with permanent atrial fibrillation? Response]
Rev Esp Cardiol. 2020 Sep 9. doi: 10.1016/j.recesp.2020.08.004. Online ahead of print. PMID: 32921874

Tamargo J, Rosano G.
Low-quality of some generic medicinal products represents a matter for growing concern.
Eur Heart J Cardiovasc Pharmacother. 2020 Jul 1;6(3):176-187. doi: 10.1093/ehjcvp/pvz037. PMID: 31501855

Hollan I, Ronda N, Dessein P, Agewall S, Karpouzas G, Tamargo J, Niessner A, Savarese G, Rosano G, Kaski JC, Wassmann S, Meroni PL.
Lipid management in rheumatoid arthritis: a position paper by the Cardiovascular Pharmacotherapy Working Group of European Society of Cardiology.
Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):104-114. doi: 10.1093/ehjcvp/pvz033. PMID: 31397840 

López-Fernández T, Martín-García A, Roldán Rabadán I, Mitroi C, Mazón Ramos P, Díez-Villanueva P, Escobar Cervantes C, Alonso Martín C, Alonso Salinas GL, Arenas M, Arrarte Esteban VI, Ayala de La Peña F, Castro Fernández A, García Pardo H, García-Sanz R, González Porras JR, López de Sá E, Lozano T, Marco Vera P, Martínez Marín V, Mesa Rubio D, Montero Á, Oristrell G, Pérez de Prado A, Velasco Del Castillo S, Virizuela Echaburu JA, Zatarain-Nicolás E, Anguita Sánchez M, Tamargo Menéndez J; Expert reviewers
Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations.
Rev Esp Cardiol (Engl Ed). 2019 Sep;72(9):749-759. doi: 10.1016/j.rec.2019.03.019. Epub 2019 Aug 9. English, Spanish. PMID: 31405794

Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A.
Oral Anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1.
Eur Heart J. 2019 Sep 21;40(36):3010-3012. doi: 10.1093/eurheartj/ehz650. PubMed PMID: 31541549.

Savarese G, Reiner MF, Uijl A, D Amario D, Agewall S, Atar D, Baumgartner I, Borghi C, De Carlo M, Drexel H, Kaski JC, Kjeldsen KP, Kucher N, Lund LH, Niessner A, Semb AG, Schmidt TA, Sulzgruber P, Tamargo J, Vitale C, Wassmann S, Aboyans V, Lewis BS.
Antithrombotic Therapy and Major Adverse Limb Events in Patients With Chronic Lower Extremity Arterial Disease: Systematic Review and Meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta & Peripheral Vascular Diseases.
Eur Heart J Cardiovasc Pharmacother. 2019 Aug 8. pii: pvz036. doi: 10.1093/ehjcvp/pvz036. [Epub ahead of print] PubMed PMID: 31392312.

Tamargo J
Happy 50th anniversary of amiodarone (1969–2019)
Int J Cardiol. 2019 Oct 15;293:115-116. doi: 10.1016/j.ijcard.2019.06.080.

Haller PM, Sulzgruber P, Kaufmann C, Geelhoed B, Tamargo J, Wassmann S, Schnabel RB, Westermann D, Huber K, Niessner A, Gremmel T.
Bleeding and ischemic outcomes in patients treated with dual or triple antithrombotic therapy - systematic review and meta-analysis.
Eur Heart J Cardiovasc Pharmacother. 2019 Oct 1;5(4):226-236. doi: 10.1093/ehjcvp/pvz021 PMID: 31198930

Ruilope LM, Ruiz-Hurtado G, Barderas MG, de la Cruz JJ, Lucia A, de la Sierra A, Gorostidi M, Vinyoles E, Segura J, Solís J, Arribas F, García-Puig J, Tamargo J, O'Brien E, Volpe M, Whelton PK, Williams B, Banegas JR.
Frequency and Prognosis of Treated Hypertensive Patients According to Prior and New Blood Pressure Goals.
Hypertension. 2019 Jul;74(1):130-136. doi: 10.1161/HYPERTENSIONAHA.119.12921. Epub 2019 May 28.

Tamargo J.
Sodium-glucose Cotransporter 2 Inhibitors in Heart Failure: Potential Mechanisms of Action, Adverse Effects and Future Developments.
Eur Cardiol. 2019 Apr;14(1):23-32. doi: 10.15420/ecr.2018.34.2. Review.

Sulzgruber P, Wassmann S, Semb AG, Doehner W, Widimsky P, Gremmel T, Kaski JC, Savarese G, Rosano GMC, Borghi C, Kjeldsen K, Torp-Pedersen C, Schmidt TA, Lewis BS, Drexel H, Tamargo J, Atar D, Agewall S, Niessner A.
Oral anticoagulation in patients with non-valvular atrial fibrillation and a CHA2DS2-VASc score of 1: a current opinion of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Council on Stroke.
Eur Heart J Cardiovasc Pharmacother. 2019 Jul 1;5(3):171-180. doi: 10.1093/ehjcvp

Tamargo J, Caballero R, Delpón E.
Pharmacotherapy for hypertension in pregnant patients: special considerations
Expert Opin Pharmacother. 2019 Jun;20(8):963-982. doi: 10.1080/14656566.2019.1594773. PMID: 30943045

Nieto-Marín P, Jiménez-Jáimez J, Tinaquero D, ALfayate S, Utrilla RG, Rodríguez Vázquez del Rey MM, Perín F, Sarquella-Brugada G, Montserrat L, Brugada J, Tercedor L, Tamargo J, Delpón E, Caballero R.
Digenic Heterozigosity in SCN5A and CACNA1C Explains the Variable Expressivity of the Long QT Phenotype in a Spanish Family
Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):324-332. doi: 10.1016/j.rec.2018.03.012.

Sanchez M, Romero M, Gómez-Guzman M, Tamargo J, Pérez-Vizcaino F, Duarte J.
Cardiovascular effects of flavonoids
Curr Med Chem. 2019;26(39):6991-7034. doi: 10.2174/0929867326666181220094721. PMID: 30569843

Tamargo J, Caballero R, Delpón E.
New drugs in preclinical and early stage clinical development in the treatment of heart failure
Expert Opin Investig Drugs. 2019;28(1):51-71. doi: 10.1080/13543784.2019.1551357. PMID:30523722

Bover Sanjuán J, Navarro-González JF, Arenas MD, Torregrosa JV, Tamargo Menéndez J, de Francisco ALM, González-Parra E, Lloret Cora MJ, Sánchez Álvarez JE, Martín-Malo A, Molina Vila P, Bajo MA, DaSilva Santos.
Pharmacological interactions of phosphate binders.
Nefrologia. 2018 Nov - Dec;38(6):573-578. doi: 10.1016/j.nefro.2018.05.003. PMID: 30473007 Epub 2018 Jul 7. [Article in English, Spanish]

Pérez-Hernández M, Matamoros M, Alfayate S, Nieto-Marín P, Utrilla RG, Tinaquero D, de Andrés R, Crespo T, Ponce-Balbuena D, Willis BC, Jiménez-Vazquez EN, Guerrero-Serna G, da Rocha AM, Campbell K, Herron TJ, Díez-Guerra FJ, Tamargo J, Jalife J, Caballero R, Delpón E.
Brugada syndrome trafficking-defective Nav1.5 channels can trap cardiac Kir2.1/2.2 channels.
JCI Insight. 2018 Sep 20;3(18). pii: 96291. doi: 10.1172/jci.insight.96291. eCollection 2018 Sep 20. PMID: 30232268

Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, Iung B, Johnson MR, Kintscher U, Kranke P, Lang IM, Morais J, Pieper PG, Presbitero P, Price S, Rosano GMC, Seeland U, Simoncini T, Swan L, Warnes CA; ESC Scientific Document Group.
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy.
Eur Heart J. 2018 Sep 7;39(34):3165-3241. doi: 10.1093/eurheartj/ehy340. PMID: 30165544

Vonbank A, Drexel H, Agewall S, Lewis BS, Dopheide JF, Kjeldsen K, Ceconi C, Savarese G, Rosano G, Wassmann S, Niessner A, Andersen Schmidt T, Saely CH, Baumgartner I, Tamargo J.
Reasons for Disparity in Statin Adherence Rates between Clinical Trials and Real World Observations. A Review.
Eur Heart J Cardiovasc Pharmacother. 2018 Oct 1;4(4):230-236. doi: 10.1093/ehjcvp/pvy028. Review. Erratum in: Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):36. Eur Heart J Cardiovasc Pharmacother. 2019 Jan 1;5(1):36. PMID: 30099530

Tamargo M, Tamargo J.
New potassium binders reduce the risk of hyperkalaemia in patients treated with renin-angiotensin-aldosterone system inhibitors.
Eur Heart J Cardiovasc Pharmacother. 2018 Oct 1;4(4):193-194. doi: 10.1093/ehjcvp/pvy019. No abstract available. PMID: 29982385

Rosano GMC, Tamargo J, Kjeldsen KP, Lainscak M, Agewall S, Anker SD, Ceconi C, Coats AJS, Drexel H, Filippatos G, Kaski JC, Lund L, Niessner A, Ponikowski P, Savarese G, Schmidt TA, Seferovic P, Wassmann S, Walther T, Lewis BS.
Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Eur Heart J Cardiovasc Pharmacother. 2018 Jul 1;4(3):180-188. doi: 10.1093/ehjcvp/pvy015. PMID: 29726985

Niessner A, Tamargo J, Koller L, Saely CH, Schmidt TA, Savarese G, Wassmann S, Rosano G, Ceconi C, Torp-Pedersen C, Kaski JC, Kjeldsen KP, Agewall S, Walther T, Drexel H, Lewis BS.
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Eur Heart J. 2018 Jun 21;39(24):2274-2281. doi: 10.1093/eurheartj/ehx625.

Ponce-Balbuena D, Guerrero-Serna G, Valdivia CR, Caballero R, Díez-Guerra FJ, Jiménez-Vázquez EN, Ramirez RJ, Monteiro da Rocha A, Herron TJ, Campbell KF, Willis BC, Alvarado FJ, Zarzoso M, Kaur K, Pérez-Hernández M, Matamoros M, Valdivia HH, Delpón E, Jalife J.
Cardiac Kir2.1 and NaV1.5 Channels Traffic Together to the Sarcolemma to Control Excitability.
Circ Res. 2018 May 25;122(11):1501-1516. doi: 10.1161/CIRCRESAHA.117.311872.

Este trabajo ha merecido una Editorial en la revista Cardiovascular Research: Strauss B, Akar FG. Kir2.1 & Nav1.5 in Sickness and in Health. Who Needs a Chaperone When They Have an Alpha Partner? Circ Res. 2018;122:1482-1484.

Subirana I, Fitó M, Diaz O, Vila J, Francés A, Delpon E, Sanchis J, Elosua R, Muñoz-Aguayo D, Dégano IR, Marrugat J.
Prediction of coronary disease incidence by biomarkers of inflammation, oxidation, and metabolism.
Sci Rep. 2018 Feb 16;8(1):3191. doi: 10.1038/s41598-018-21482-y

Dan GA, Martinez-Rubio A, Agewall S, Boriani G, Borggrefe M, Gaita F, van Gelder I, Gorenek B, Kaski JC, Kjeldsen K, Lip GYH, Merkely B, Okumura K, Piccini JP, Potpara T, Poulsen BK, Saba M, Savelieva I, Tamargo JL, Wolpert C; ESC Scientific Document Group.
Antiarrhythmic drugs-clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology (ESC) Working Group on Cardiovascular Pharmacology, endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS) and International Society of Cardiovascular Pharmacotherapy (ISCP)
Europace. 2018 May 1;20(5):731-732an. doi: 10.1093/europace/eux373. No abstract available. Erratum in: Europace. 2018 May 1;20(5):738. PMID: 29438514

Tamargo J, Caballero R, Delpón E.
New Therapeutic Approaches for the Treatment of Hyperkalemia in Patients Treated with Renin-Angiotensin-Aldosterone System Inhibitors
Cardiovasc Drugs Ther. 2018 Feb;32(1):99-119. doi: 10.1007/s10557-017-6767-5.

Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I; ESC Scientific Document Group .
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS).
Eur Heart J. 2018 Mar 1;39(9):763-816. doi: 10.1093/eurheartj/ehx095.

Authors/Task Force Members, Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, Document Reviewers, Widimsky P, Kolh P, Agewall S, Bueno H, Coca A, De Borst GJ, Delgado V, Dick F, Erol C, Ferrini M, Kakkos S, Katus HA, Knuuti J, Lindholt J, Mattle H, Pieniazek P, Piepoli MF, Scheinert D, Sievert H, Simpson I, Sulzenko J, Tamargo J, Tokgozoglu L, Torbicki A, Tsakountakis N, Tuñón J, de Ceniga MV, Windecker S, Zamorano JL.
Editor's Choice - 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Eur J Vasc Endovasc Surg. 2018 Mar;55(3):305-368. doi: 10.1016/j.ejvs.2017.07.018.

Utrilla RG, Nieto-Marín P, Alfayate S, Tinaquero D, Matamoros M, Pérez-Hernández M, Sacristán S, Ondo L, de Andrés R, Díez-Guerra FJ, Tamargo J, Delpón E, Caballero R.
Kir2.1-Nav1.5 Channel Complexes Are Differently Regulated than Kir2.1 and Nav1.5 Channels Alone.
Front Physiol. 2017 Nov 14;8:903. doi: 10.3389/fphys.2017.00903. eCollection 2017.

Authors/Task Force Members, Aboyans V, Ricco JB, Bartelink MEL, Björck M, Brodmann M, Cohnert T, Collet JP, Czerny M, De Carlo M, Debus S, Espinola-Klein C, Kahan T, Kownator S, Mazzolai L, Naylor AR, Roffi M, Röther J, Sprynger M, Tendera M, Tepe G, Venermo M, Vlachopoulos C, Desormais I, Document Reviewers, Widimsky P, Kolh P, Agewall S, Bueno H, Coca A, De Borst GJ, Delgado V, Dick F, Erol C, Ferrini M, Kakkos S, Katus HA, Knuuti J, Lindholt J, Mattle H, Pieniazek P, Piepoli MF, Scheinert D, Sievert H, Simpson I, Sulzenko J, Tamargo J, Tokgozoglu L, Torbicki A, Tsakountakis N, Tuñón J, de Ceniga MV, Windecker S, Zamorano JL.
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
Eur J Vasc Endovasc Surg. 2017 Aug 26. pii: S1078-5884(17)30454-9. doi: 10.1016/j.ejvs.2017.07.018. [Epub ahead of print]

Ruilope LM, Tamargo J.
Renin-angiotensin system blockade: Finerenone.
Nephrol Ther. 2017 Apr;13 Suppl 1:S47-S53. doi: 10.1016/j.nephro.2017.02.003. Review.

Tamargo M, Tamargo J.
Future drug discovery in renin-angiotensin-aldosterone system intervention.
Expert Opin Drug Discov. 2017 Aug;12(8):827-848. doi: 10.1080/17460441.2017.1335301. Epub 2017 Jun 9. Review.

Coll-Vinent B, Martín A, Sánchez J, Tamargo J, Suero C, Malagón F, Varona M, Cancio M, Sánchez S, Carbajosa J, Ríos J, Casanovas G, Ràfols C, Del Arco C; EMERG-AF Investigators.
Benefits of Emergency Departments' Contribution to Stroke Prophylaxis in Atrial Fibrillation: The EMERG-AF Study (Emergency Department Stroke Prophylaxis and Guidelines Implementation in Atrial Fibrillation).
Stroke. 2017 May;48(5):1344-1352. doi: 10.1161/STROKEAHA.116.014855.

Ruilope LM, Tamargo J.
Aldosterone a Relevant Factor in the Beginning and Evolution of Arterial Hypertension.
Am J Hypertens. 2017 May 1;30(5):468-469. doi: 10.1093/ajh/hpx010.

Tamargo J, Rosano G, Walther T, Duarte J, Niessner A, Kaski JC, Cecconi C, Drexel H, Kjeldsen K, Savarese G, Torp-Pedersen C, Atar D, Lewis BS, Agewall S.
Gender differences in the effects of cardiovascular drugs.
Eur Heart J Cardiovasc Pharmacother. 2017 Jul 1;3(3):163-182. doi: 10.1093/ehjcvp/pvw042.

Tamargo J, Rosano GM, Delpón E, Ruilope L, López-Sendón J.
Pharmacological reasons that may explain why randomized clinical trials have failed in acute heart failure syndromes.
Int J Cardiol. 2017 Apr 15;233:1-11. doi: 10.1016/j.ijcard.2016.11.124. Review.

Stefan Agewall, John Camm, Gonzalo Barón Esquivias, Werner Budts, Scipione Carerj, Filip Casselman, Antonio Coca, Raffaele De Caterina, Spiridon Deftereos, Dobromir Dobrev, José M Ferro, Gerasimos Filippatos, Donna Fitzsimons, Bulent Gorenek, Maxine Guenoun, Stefan H Hohnloser, Philippe Kolh, Gregory YH Lip, Athanasios Manolis, John McMurray, Piotr Ponikowski, Raphael Rosenhek, Frank Ruschitzka, Irina Savelieva, Sanjay Sharma, Piotr Suwalski, Juan Luis Tamargo, Clare J Taylor, Isabelle C Van Gelder, Adriaan A Voors, Stephan Windecker, José Luis Zamorano, Katja Zeppenfeld, Grupo de Trabajo de la Sociedad Europea de Cardiología.
Guía ESC 2016 sobre el diagnóstico y tratamiento de la fibrilación auricular, desarrollada en colaboración con la EACTS.
Rev Esp Cardiol. 2017;70(1):e1/50-e84. doi: 10.1016/j.recesp.2016.11.014

Vonbank A, Agewall S, Kjeldsen KP, Lewis BS, Torp-Pedersen C, Ceconi C, Funck-Brentano C, Kaski JC, Niessner A, Tamargo J, Walther T, Wassmann S, Rosano G, Schmidt H, Saely CH, Drexel H.
Comprehensive efforts to increase adherence to statin therapy.
2017 Aug 21;38(32):2473-2479. doi: 10.1093/eurheartj/ehw628.

Caballero R, Utrilla RG, Amorós I, Matamoros M, Pérez-Hernández M, Tinaquero D, Alfayate S, Nieto-Marín P, Guerrero-Serna G, Liu QH, Ramos-Mondragón R, Ponce-Balbuena D, Herron T, Campbell KF, Filgueiras-Rama D, Peinado R, López-Sendón JL, Jalife J, Delpón E, Tamargo J.
Tbx20 controls the expression of the KCNH2 gene and of hERG channels.
Proc Natl Acad Sci U S A. 2017 Jan 17;114(3):E416-E425. doi: 10.1073/pnas.1612383114. PMID: 28049825

Arribas F; SEC Working Group for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:., Arribas F, Roldán I, Luis Merino J, Roldán V, Arenal Ÿ, Tamargo J, Ruiz-Granell R, Mont L, Anguita M, Marín F; Reviewers for the 2016 ESC Guidelines for the Management of Atrial Fibrillation:., Barrios Alonso V, Barón G, Esquivias, Cosín Sales J, Díaz Infante E, Escobar Cervantes C, Ferreiro Gutiérrez JL, Guerra Ramos JM, Jiménez Candil FJ, Pérez Castellano N, Sambola Ayala A, Tello Montoliu A; SEC Guidelines Committee:., San Román A, Alfonso F, Arribas F, Evangelista A, Ferreira I, Jiménez M, Marín F, de Isla LP, Rodríguez Padial L, Sánchez PL, Sionis A, Vázquez R.
Comments on the 2016 ESC Guidelines for the Management of Atrial Fibrillation.
Rev Esp Cardiol (Engl Ed). 2017 Jan;70(1):2-8. doi: 10.1016/j.rec.2016.11.032. PMID: 28038728

Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM, Zamorano JL, Aboyans V, Achenbach S, Agewall S, Badimon L, Barón-Esquivias G, Baumgartner H, Bax JJ, Bueno H, Carerj S, Dean V, Erol Ç, Fitzsimons D, Gaemperli O, Kirchhof P, Kolh P, Lancellotti P, Lip GY, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Roffi M, Torbicki A, Vaz Carneiro A, Windecker S; Authors/Task Force Members.; ESC Committee for Practice Guidelines (CPG).; Document Reviewers.
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Eur J Heart Fail. 2017 Jan;19(1):9-42. doi: 10.1002/ejhf.654.

Cañón S, Caballero R, Herraiz-Martínez A, Pérez-Hernández M, López B, Atienza , Jalife J, Hove-Madsen L, Delpón E, Bernad A.
miR-208b upregulation interferes with calcium handling in HL-1 atrial myocytes: Implications in human chronic atrial fibrillation.
J Mol Cell Cardiol. 2016 Oct;99:162-173. doi: 0.1016/j.yjmcc.2016.08.012.

Tamargo J
Mechanism of Action of LCZ696
Cardiac Failure Review, 2016;2(1):40-6 doi: 10.15420/cfr.2016:1:1

Rivera-Torres J, Calvo CJ, Llach A, Guzmán-Martínez G, Caballero R, González-Gómez C, Jiménez-Borreguero LJ, Guadix JA, Osorio FG, López-Otín C, Herraiz-Martínez A, Cabello N, Vallmitjana A, Benítez R, Gordon LB, Jalife J, Pérez-Pomares JM, Tamargo J, Delpón E, Hove-Madsen L, Filgueiras-Rama D, Andrés V.
Cardiac electrical defects in progeroid mice and Hutchinson-Gilford progeria syndrome patients with nuclear lamina alterations.
Proc Natl Acad Sci U S A. 2016 Nov 15;113(46):E7250-E7259.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P; Authors/Task Force Members; Document Reviewers: Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, et al.
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO).
Europace. 2016 Nov;18(11):1609-1678.PubMed PMID: 27567465.

Tamargo J, Ruilope LM.
Investigational calcium channel blockers for the treatment of hypertension
Expert Opin Investig Drugs. 2016 Oct 4. PubMed PMID: 27696904.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K.
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.
Eur J Cardiothorac Surg. 2016 Nov;50(5):e1-e88. PMID: 27663299.

Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P; Authors/Task Force Members.; Document Reviewers: Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, et al.
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS: The Task Force for the management of atrial fibrillation of the European Society of Cardiology (ESC)Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESCEndorsed by the European Stroke Organisation (ESO).
Eur Heart J. 2016 Oct 7;37(38):2893-2962. doi: 10.1093/eurheartj/ehw210.

Zamorano JL, Lancellotti P, Rodriguez Muñoz D, Aboyans V, Asteggiano R, Galderisi M, Habib G, Lenihan DJ, Lip GY, Lyon AR, Lopez Fernandez T, Mohty D, Piepoli MF, Tamargo J, Torbicki A, Suter TM; Authors/Task Force Members.; ESC Committee for Practice Guidelines (CPG).
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC).
Eur Heart J. 2016 Sep 21;37(36):2768-2801. PubMed PMID: 27567406.

Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C.
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):108-18. doi: 10.1093/ehjcvp/pvv054. PubMed PMID: 27533522.

Zannad F, Stough WG, Lipicky RJ, Tamargo J, Bakris GL, Borer JS, Alonso García Mde L, Hadjadj S, Koenig W, Kupfer S, McCullough PA, Mosenzon O, Pocock S, Scheen AJ, Sourij H, Van der Schueren B, Stahre C, White WB, Calvo G.
Assessment of cardiovascular risk of new drugs for the treatment of diabetes mellitus: risk assessment vs. risk aversion.
Eur Heart J Cardiovasc Pharmacother. 2016 Jul;2(3):200-5. doi: 10.1093/ehjcvp/pvw007. Epub 2016 Apr 3. Review. PubMed PMID: 27418973; PubMed Central PMCID: PMC4907355.

Ambrosio G, Komajda M, Mugelli A, Lopez-Sendón J, Tamargo J, Camm J.
Management of stable angina: A commentary on the European Society of Cardiology guidelines.
Eur J Prev Cardiol. 2016 Sep;23(13):1401-12. doi: 10.1177/2047487316648475. Epub 2016 May 24. PubMed PMID: 27222385.

Romero M, Jiménez R, Toral M, León-Gómez E, Gómez-Gúzman M, Sánchez M, Zarzuelo MJ, Rodríguez-Gómez I, Rath G, Tamargo J, Pérez-Vizcaíno F, Dessy C, Duarte J.
Vascular and Central Activation of Peroxisome Proliferator-Activated Receptor-β Attenuates Angiotensin II-Induced Hypertension: Role of RGS-5. J
Pharmacol Exp Ther. 2016 Jul;358(1):151-63. doi: 10.1124/jpet.116.233106. Epub 2016 Apr 27. PubMed PMID: 27189971.

Toral M, Romero M, Jiménez R, Robles-Vera I, Tamargo J, Martínez MC, Pérez-Vizcaíno F, Duarte J.
Role of UCP2 in the protective effects of PPARβ/δ activation on lipopolysaccharide-induced endothelial dysfunction.
Biochem Pharmacol. 2016 Jun 15;110-111:25-36. doi: 10.1016/j.bcp.2016.05.004. Epub 2016 May 12. PubMed PMID: 27179975.

Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C.
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Eur Heart J. 2016 Apr 1;37(13):1015-23. doi: 10.1093/eurheartj/ehv505.

Ambrosio G, Tamargo J, Grant PJ.
Non-haemodynamic anti-anginal agents in the management of patients with stable coronary artery disease and diabetes: A review of the evidence.
Diab Vasc Dis Res. 2016 Mar;13(2):98-112. doi:10.1177/1479164115609028.

Matamoros M, Pérez-Hernández M, Guerrero-Serna G, Amorós I, Barana A, Núñez M, Ponce-Balbuena D, Sacristán S, Gómez R, Tamargo J, Caballero R, Jalife J, Delpón E.
Nav1.5 N-terminal domain binding to α1-syntrophin increases membrane density of human Kir2.1, Kir2.2 and Nav1.5 channels.
Cardiovasc Res. 16 May 15;110(2):279-90. doi: 10.1093/cvr/cvw009.

Este trabajo ha merecido una Editorial en la revista Cardiovascular Research: Mohler PJ, Abriel H. Complexity of cardiac ion channel macromolecular complexes. Cardiovasc Res. 2016 May 15;110(2):163-4. doi: 10.1093/cvr/cvw055.

Pérez-Hernández M, Matamoros M, Barana A, Amorós I, Gómez R, Núñez M, Sacristán S, Pinto Á, Fernández-Avilés F, Tamargo J, Delpón E, Caballero R.
Pitx2c increases in atrial myocytes from chronic atrial fibrillation patients enhancing IKs and decreasing ICa,L.
Cardiovasc Res. 2016 Mar 1;109(3):431-41. doi: 10.1093/cvr/cvv280.

Este trabajo ha merecido una Editorial en la revista Cardiovascular Research: Li N, Dobrev D, Wehrens XH. PITX2: a master regulator of cardiac channelopathy in atrial fibrillation? Cardiovasc Res. 2016 Mar 1;109(3):345-7. doi: 10.1093/cvr/cvw008.

Ferrari R, Bertini M, Blomstrom-Lundqvist C, Dobrev D, Kirchhof P, Pappone C, Ravens U, Tamargo J, Tavazzi L, Vicedomini GG.
An update on atrial fibrillation in 2014: From pathophysiology to treatment.
Int J Cardiol. 2016 Jan 15;203:22-9. doi: 10.1016/j.ijcard.2015.10.089.

Tamargo J, Caballero R, Delpón E.
The Renin-Angiotensin System and Bone.
Clinic Rev Bone Miner Metab. 2015;13:125-148.

Tamargo J, Castellano JM, Fuster V.
The Fuster-CNIC-Ferrer Cardiovascular Polypill: a polypill for secondary cardiovascular prevention.
Int J Cardiol. 2015 Dec;201 Suppl 1:S15-22. doi: 10.1016/S0167-5273(15)31028-7.

Niessner A, Tamargo J, Morais J, Koller L, Wassmann S, Husted SE, Torp-Pedersen C, Kjeldsen K, Lewis BS, Drexel H, Kaski JC, Atar D, Storey RF, Lip GY, Verheugt FW, Agewall S.
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis. Eur
Heart J. 2017 Jun 7;38(22):1710-1716. doi: 10.1093/eurheartj/ehv676. Review.

Authors/Task Force Members , Habib G , Lancellotti P , Antunes MJ , Bongiorni MG , Casalta JP , Del Zotti F , Dulgheru R , El Khoury G , Erba PA , Iung B , Miro JM , Mulder BJ , Plonska-Gosciniak E , Price S , Roos-Hesselink J , Snygg-Martin U , Thuny F , Tornos Mas P , Vilacosta I , Zamorano JL.
2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).
Eur Heart J. 2015 Nov 21;36(44):3075-128. doi: 10.1093/eurheartj/ehv319.

Camm AJ, Manolis A, Ambrosio G, Daly C, Komajda M, Lopez de Sa E, Lopez-Sendon JL, Mugelli A, Muggli F, Tamargo J.
Unresolved issues in the management of chronic stable angina.
Int J Cardiol. 2015 Dec 15;201:200-7. doi: 10.1016/j.ijcard.2015.08.045.

Rosano GM, Lewis B, Agewall S, Wassmann S, Vitale C, Schmidt H, Drexel H, Patak A, Torp-Pedersen C, Kjeldsen KP, Tamargo J.
Gender differences in the effect of cardiovascular drugs: a position document of the Working Group on Pharmacology and Drug Therapy of the ESC.
Eur Heart J . 2015 Oct 21;36(40):2677-80.

Daimi H, Lozano-Velasco E, Haj Khelil A, Chibani JB, Barana A, Amorós I, González de la Fuente M, Caballero R, Aranega A, Franco D.
Regulation of SCN5A by microRNAs: miR-219 modulates SCN5A transcript expression and the effects of flecainide intoxication in mice.
Heart Rhythm. 2015 Jun;12(6):1333-42. doi: 10.1016/j.hrthm.2015.02.018.

Tamargo J, Le Heuzey JY, Mabo P.
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide.
Eur J Clin Pharmacol. 2015 May;71(5):549-67.

Tamargo J, Caballero R, Delpón E.
Cancer chemotherapy and cardiac arrhythmias: a review.
Drug Saf. 2015 Feb;38(2):129-52.

Tamargo J, Duarte J, Ruilope LM.
New Antihypertensive Drugs Under Development.
Curr Med Chem. 2015;22(3):305-42

Tamargo J, Caballero R, Delpón E.
New drugs for the treatment of hyperkalemia in patients treated with renin-angiotensin-aldosterone system inhibitors -- hype or hope?
Discov Med. 2014 Nov;18(100):249-54

Gómez R, Caballero R, Barana A, Amorós I, Haida de Palm S, Matamoros M, Núñez M, Pérez-Hernández M, Iriepa I, Tamargo J, Delpón E.
Structural bases of drugs that increase cardiac inward rectifier Kir2.1 currents
Cardiovasc Res. 2014 Nov 1;104(2):337-46

Gómez-Doblas JJ, Muñiz J, Martin JJ, Rodríguez-Roca G, Lobos JM, Awamleh P, Permanyer-Miralda G, Chorro FJ, Anguita M, Roig E; OFRECE study collaborators.
Prevalence of atrial fibrillation in Spain. OFRECE study results
Rev Esp Cardiol (Engl Ed). 2014 Apr;67(4):259-69

Kolh P, Windecker S, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A; ESC Committee for Practice Guidelines, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol Ç, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; EACTS Clinical Guidelines Committee, Sousa Uva M, Achenbach S, Pepper J, Anyanwu A, Badimon L, Bauersachs J, Baumbach A, Beygui F, Bonaros N, De Carlo M, Deaton C, Dobrev D, Dunning J, Eeckhout E, Gielen S, Hasdai D, Kirchhof P, Luckraz H, Mahrholdt H, Montalescot G, Paparella D, Rastan AJ, Sanmartin M, Sergeant P, Silber S, Tamargo J, ten Berg J, Thiele H, van Geuns RJ, Wagner HO, Wassmann S, Wendler O, Zamorano JL.
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Eur J Cardiothorac Surg. 2014 Oct;46(4):517-92

Authors/Task Force Members, Konstantinides S, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galiè N, Gibbs JS, Huisman M, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Noordegraaf AV, Zamorano JL, Zompatori M; Authors/Task Force Members.
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism: The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the European Respiratory Society (ERS)
Eur Heart J. 22014 Nov 14;35(43):3033-73

Authors/Task Force members, Erbel R, Aboyans V, Boileau C, Bossone E, Di Bartolomeo R, Eggebrecht H, Evangelista A, Falk V, Frank H, Gaemperli O, Grabenwöger M, Haverich A, Iung B, Manolis AJ, Meijboom F, Nienaber CA, Roffi M, Rousseau H, Sechtem U, Sirnes PA, von Allmen RS, Vrints CJ; Authors/Task Force members.
2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: Document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adultThe Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC).
Eur Heart J. 2014 Nov 1;35(41):2873-926

Authors/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A; Authors/Task Force members.
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
Eur Heart J. Eur Heart J. 2014 Oct 1;35(37):2541-619

Authors/Task Force members, Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege AA, Lafont A, Limongelli G, Mahrholdt H, McKenna WJ, Mogensen J, Nihoyannopoulos P, Nistri S, Pieper PG, Pieske B, Rapezzi C, Rutten FH, Tillmanns C, Watkins H; Authors/Task Force members.
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).
Eur Heart J. 2014 Oct 14;35(39):2733-79

Task Force Members, Lip GY, Windecker S, Huber K, Kirchhof P, Marin F, Ten Berg JM, Haeusler KG, Boriani G, Capodanno D, Gilard M, Zeymer U, Lane D; Document Reviewers, Storey RF, Bueno H, Collet JP, Fauchier L, Halvorsen S, Lettino M, Morais J, Mueller C, Potpara TS, Rasmussen LH, Rubboli A, Tamargo J, Valgimigli M, Zamorano JL.
Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS).
Eur Heart J. 2014;35:3455-79.

Authors/Task Force Members, Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, De Hert S, Ford I, Gonzalez-Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Lüscher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Sousa-Uva M, Voudris V, Funck-Brentano C; Authors/Task Force Members.
2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)
Eur Heart J. 2014 Sep 14;35(35):2383-431

Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD), Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL.
ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - summary.
Diab Vasc Dis Res. 2014 May;11(3):133-73

TheTask Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA), Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE.
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Rev Esp Cardiol (Engl Ed). 2014 Jan;67(1):58

Tamargo J, Solini A, Ruilope LM.
Comparison of agents that affect aldosterone action
Seminars in Nephrology 2014;34:285-306

Barana A, Matamoros M, Dolz-Gaitón P, Pérez-Hernández M, Amorós I, Núñez M, Sacristán S, Pedraz A., Pinto A, Fernández-Avilés F, Tamargo J, Delpón E, Caballero R.
Chronic atrial fibrillation increases microRNA- 21 in human atrial myocites decreasing L-type calcium current
Circulation Circ Arrhythm Electrophysiol. 2014 Oct;7(5):861-8

Tamargo J, Segura J, Ruilope LM
Diuretics in the treatment of hypertension. Part 2: loop diuretics and potassium-sparing agents.
Expert Opin Pharmacother 2014;15:605-621

Tamargo J, Segura J, Ruilope LM
Diurectis in the treatment of hypertension. Part 1: thiazide and thiazide-like diuretics.
Expert Opin Pharmacother 2014;15:527-547

Modrego H, Azcona L, Martín-Palacios N, Zamorano-León JJ, Segura A, Rodríguez P, Guerra R, Tamargo J, Macaya C
Platelet content of nitric oxide synthase 3 phosphorylated at serie is associated with the functional response of platelet to aspirin
PlosOne 2013;8(12):e82574. doi: 10.1371/journal.pone.0082574.

Dolz-Gaitón P, Núñez M, Núñez L, Barana A, Amorós I, Matamoros M, Pérez-Hernández M, Pérez-Hernández M, González de la fuente M, Álvarez-López M, Macías-Ruiz R, Tercedor-Sánchez L, Jiménez-Jaímez J, Delpón E, Caballero R, Tamargo J.
Functional characterization of a novel frameshift mutation in the C-terminus of the Nav1.5 channel underlying a Brugada Syndrome with variable expression in a spanish family
PlosOne 2013 8(11):e81493

Zarzuelo MJ, López-Sepúlveda R, Sánchez M, Romero M, Gómez-Guzmán M, Ungvary Z, Pérez-Vizcaíno F, Jiménez R, Duarte J
SIRT1 inhibits NADPH oxidase activation and protects endothelial function in the rat aorta: implications for vascular aging.
Biochem Pharmacol. 2013 May 1;85(9):1288-96.

Task Force Members, Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A, Bugiardini R, Crea F, Cuisset T, Di Mario C, Ferreira JR, Gersh BJ, Gitt AK, Hulot JS, Marx N, Opie LH, Pfisterer M, Prescott E, Ruschitzka F, Sabaté M, Senior R, Taggart DP, van der Wall EE, Vrints CJ; ESC Committee for Practice Guidelines (CPG), Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Knuuti J, Valgimigli M, Bueno H, Claeys MJ, Donner-Banzhoff N, Erol C, Frank H, Funck-Brentano C, Gaemperli O, Gonzalez-Juanatey JR, Hamilos M, Hasdai D, Husted S, James SK, Kervinen K, Kolh P, Kristensen SD, Lancellotti P, Maggioni AP, Piepoli MF, Pries AR, Romeo F, Rydén L, Simoons ML, Sirnes PA, Steg PG, Timmis A, Wijns W, Windecker S, Yildirir A, Zamorano JL.
2013 ESC guidelines on the management of stable coronary artery disease: The Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Eur Heart J. 2013 Oct;34(38):2949-3003.

Authors/Task Force Members, Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL; ESC Committee for Practice Guidelines (CPG), Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, De Backer G, Sirnes PA, Ezquerra EA, Avogaro A, Badimon L, Baranova E, Baumgartner H, Betteridge J, Ceriello A, Fagard R, Funck-Brentano C, Gulba DC, Hasdai D, W Hoes A, Kjekshus JK, Knuuti J, Kolh P, Lev E, Mueller C, Neyses L, Nilsson PM, Perk J, Ponikowski P, Reiner Z, Sattar N, Schächinger V, Scheen A, Schirmer H, Strömberg A, Sudzhaeva S, Tamargo JL, Viigimaa M, Vlachopoulos C, Xuereb RG.
ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: The Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).
Eur Heart J. 2013;34(39):3035-87. doi: 10.1093/eurheartj/eht108.

Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F; Task Force Members.
2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
J Hypertens. 2013 Jul;31(7):1281-357.
doi: 10.1097/01.hjh.0000431740.32696.cc.

European Society of Cardiology (ESC); European Heart Rhythm Association (EHRA), Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE.
2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
Europace. 2013 Aug;15(8):1070-118.
doi: 10.1093/europace/eut206.

Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE; ESC Committee for Practice Guidelines (CPG), Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S; Document Reviewers, Kirchhof P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bänsch D, Baumgartner H, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Hasdai D, Hoes AW, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM, Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC, Wilson CM.
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
Eur Heart J. 2013 Aug;34(29):2281-329.
doi: 10.1093/eurheartj/eht150.

Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Redon J, Dominiczak A, Narkiewicz K, Nilsson PM, Burnier M, Viigimaa M, Ambrosioni E, Caufield M, Coca A, Olsen MH, Schmieder RE, Tsioufis C, van de Borne P, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Clement DL, Coca A, Gillebert TC, Tendera M, Rosei EA, Ambrosioni E, Anker SD, Bauersachs J, Hitij JB, Caulfield M, De Buyzere M, De Geest S, Derumeaux GA, Erdine S, Farsang C, Funck-Brentano C, Gerc V, Germano G, Gielen S, Haller H, Hoes AW, Jordan J, Kahan T, Komajda M, Lovic D, Mahrholdt H, Olsen MH, Ostergren J, Parati G, Perk J, Polonia J, Popescu BA, Reiner Z, Rydén L, Sirenko Y, Stanton A, Struijker-Boudier H, Tsioufis C, van de
Borne P, Vlachopoulos C, Volpe M, Wood DA.
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).
Eur Heart J. 2013 Jul;34(28):2159-219.
doi: 10.1093/eurheartj/eht151.

Zarzuelo MJ, Gómez-Guzmán M, Jiménez R, Quintela AM, Romero M, Sánchez M, Zarzuelo A, Tamargo J, Pérez-Vizcaíno F, Duarte J.
Effects of peroxisome proliferator-activated receptor-β activation in endothelin-dependent.
hypertension.
Cardiovasc Res. 2013 Sep 1;99(4):622-31.
doi: 10.1093/cvr/cvt152.

American College of Cardiology Foundation; American Heart Association; European Society of Cardiology; Heart Rhythm Society, Wann LS, Curtis AB, Ellenbogen KA, Estes NA, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey J, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS. Collaborators: Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman E, Pressler SJ, Sellke FW, Shen WK. Wisconsin Heart and Vascular Clinic, Department of Cardiovascular Medicine, USA.
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines
Circulation. 2013 May 7;127(18):1916-26.
doi: 10.1161/CIR.0b013e318290826d

Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH, DeMets D, Guyton RA, Hochman JS, Kovacs RJ, Ohman EM, Pressler SJ, Sellke FW, Shen WK, Wann LS, Curtis AB, Ellenbogen KA, Estes NA 3rd, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Le Heuzey JY, Kay GN, Olsson SB, Prystowsky EN, Tamargo JL, Wann S.
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
J Am Coll Cardiol. 2013 May 7;61(18):1935-44
doi: 10.1016/j.jacc.2013.02.001

Grupa Robocza Europejskiego Towarzystwa Kardiologicznego (ESC), Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Sousa Uva M, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL; European Association for the Study of Diabetes (EASD).
ESC guidelines on diabetes, pre-diabetes and diseases of the cardiovascular system developed in cooperation with the EASD
Kardiol Pol. 2013;71 Suppl 11:S319-94

Amorós I, Dolz-Gaitón P, Gómez R, Matamoros M, Barana A, de la Fuente MG, Núñez M, Pérez-Hernández M, Moraleda I, Gálvez E, Iriepa I, Tamargo J, Caballero R, Delpón E
Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic pore
Biochem Pharmacol. 2013 Jul 15;86(2):267-78.
doi: 10.1016/j.bcp.2013.04.023

Núñez L, Barana A, Amorós I, de la Fuente MG , Dolz-Gaitón P, Gómez R, Rodríguez-García I, Mosquera I, Monserrat L, Delpón E, Caballero R, Castro-Beiras A, Tamargo J.
p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient
Heart Rhythm. 2013;10(2):264-272
doi: E pii: S1547-5271(12)01238-6. 10.1016/j.hrthm.2012.10.025

González de la Fuente M , Barana A, Gómez R, Amorós I, Dolz-Gaitón P, Sacristán S, Atienza F, Pita A, Pinto A, Fernández-Avilés F, Caballero R, Tamargo J, Delpón E.
Chronic atrial fibrillation up-regulates ß1-Adrenoceptors affecting repolarizing currents and action potential duration
Cardiovasc Res. 2013;97(2):379-88
doi: 10.1093/cvr/cvs313

Tamargo J , Caballero R , Delpón E
Drug-induced atrial fibrillation: Does it matter?
Discov Med. 2012 Nov;14(78):295-9

Tamargo J.
TGFß3 mutations cause arrhythmogenic right ventricular dysplasia type 1 and open the door to understanding the biological role of TGFß3 (where there's a will, there's a way)
Cardiovasc Res. 2012 Nov 1;96(2):188-90
doi: 10.1093/cvr/cvs231

Tamargo J, Caballero R, Delpón E.
Drug-induced atrial fibrillation.
Expert Opin Drug Saf. 2012;11:615-34.

Quintela AM, Jiménez R, Gómez-Guzmán M, José Zarzuelo M, Galindo P, Sánchez M, Vargas F, Cogolludo A, Tamargo J, Pérez-Vizcaíno F, Duarte J.
Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR β/δ) prevents endothelial dysfunction in type 1 diabetic rats.
Free Radic Biol Med. 2012; 53:730-41

Tamargo J, Capucci A, Mabo P.
Safety of flecainide.
Drug Saf. 2012;35(4):273-89.

López-Farré AJ, Zamorano-León JJ, Segura A, Mateos-Cáceres PJ, Modrego J, Rodríguez-Sierra P, Calatrava L, Tamargo J, Macaya C.
Plasma Desmoplakin I Biomarker Of Vascular Recurrence After Ischemic Stroke.
J Neurochem. 2012; 121(2):314-25.

Gómez-Guzmán M, Jiménez R, Sánchez M, Zarzuelo MJ, Galindo P, Quintela AM, López-Sepúlveda R, romero M, Tamargo J, Vargas F, Pérez-Vizcaíno F, Duarte J.
Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NDPH oxidase actividy in DOCA-salt hypertension.
Free Radic Biol Med. 2012;52(1):70-9.

Galindo P, Rodriguez-Gómez I, González-Manzano S, Dueñas M, Jiménez R, Menéndez C, Vargas F, Tamargo J, Santos-Buelga C, Pérez-Vizcaíno F, Duarte J.
Glucuronidated Quercetin Lowers Blood Pressure in Spontaneously Hypertensive Rats via Deconjugation.
PLoS One. 2012;7(3):e32673.

Tamargo J, Duarte J, Caballero R, Delpón E.
New therapeutic targets for the development of positive inotropic agents.
Discov Med. 2011 Nov;12(66):381-92.

Zarzuelo MJ, Jiménez R, Galindo P, Sánchez M, Nieto A, Romero M, Quintela AM, López-Sepúlveda R, Gómez-Guzmán M, Bailón E, Rodríguez-Gómez I, Zarzuelo A, Gálvez J, Tamargo J, Pérez-Vizcaíno F, Duarte J.
Antihypertensive Effects of Peroxisome Proliferator-Activated Receptor-{beta} Activation in Spontaneously Hypertensive Rats.
Hypertension. 2011;58:733-743

Tamargo J, López-Sendón J.
Novel therapeutic targets for the treatment of heart failure.
Nat Rev Drug Discov. 2011;10:536-555
Factor de Impacto: 28.712

Tamargo J, Caballero R, Delpón E.
Ranolazine: an antianginal drug with antiarrhythmic properties.
Expert Rev Cardiovasc Ther. 2011;9:815-827.

López-Sepúlveda R, Gómez-Guzmán M, Zarzuelo MJ, Romero M, Sánchez M , Quintela AM, Galindo P, O'Valle F, Tamargo J , Perez-Vizcaino F, Duarte J , Jimenez R
Red wine polyphenols prevent endothelial dysfunction induced by endothelin-1 in rat aorta: role of NADPH oxidase.
Clin. Sci. 2011; 120: 321-33

Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J.
Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation.
Europace 2011;13:161-73 Factor de Impacto: 1.871

Amorós I, Jiménez-Jáimez J, Tercedor L, Barana A, Gómez R, de la Fuente MG , Dolz-Gaitón P, Alvarez M, Martínez-Espín E, Lorente JA, Melgares R, Tamargo J, Delpón E, Caballero R.
Functional effects of a missense mutation in HERG associated with type 2 Long QT syndrome.
Heart Rhythm 2011;8:463-470. Factor de Impacto: 4.559

López-Farré AJ , Zamorano-León JJ , Azcona L , Modrego J , Mateos-Cáceres PJ , González-Armengol J, Villarroel P, Moreno-Herrero R, Rodríguez-Sierra P, Segura A, Tamargo J, Macaya C-
Proteomic changes related to "bewildered" circulating platelets in the acute coronary syndrome.
Proteomics 2011; 11: 3335-48

Chinchilla A, Daimi H, Lozano-Velasco E, Dominguez JN, Caballero R, Delpón E, Tamargo J, Cinca J, Hove-Madsen L, Aranega AE, Franco D.
PITX2 Insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis.
Circ Cardiovasc Genet. 2011;4:269-279.

Tamargo J, López-Farré A, Caballero R, Delpón E.
Dronedarone.
Drugs Today (Barc). 2011;47:109-133.

Wann LS, Curtis AB, Ellenbogen KA, Estes NA 3rd, Ezekowitz MD, Jackman WM, January CT, Lowe JE, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Heuzey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Jacobs AK, Anderson JL, Albert N, Creager MA, Ettinger SM, Guyton RA, Halperin JL, Hochman JS, Kushner FG, Ohman EM, Stevenson WG, Yancy CW.
2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Heart Rhythm. 2011;8:e1-8. Factor de Impacto: 4.559

Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM; 2006 WRITING COMMITTEE MEMBERS, Fuster V, Rydén LE, Cannom DS, Le Heuzey JY, Crijns HJ, Lowe JE, Curtis AB, Olsson SB, Ellenbogen KA, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Wann LS; ACCF/AHA TASK FORCE MEMBERS, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Stevenson WG, Guyton RA, Tarkington LG, Halperin JL, Yancy CW.
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Heart Rhythm. 2011;8:157-76. Factor de Impacto: 4.559

Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM, Fuster V, Rydén LE, Cannom DS, Le Heuzey JY, Crijns HJ, Lowe JE, Curtis AB, Olsson SB, Ellenbogen KA, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Wann LS, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Stevenson WG, Guyton RA, Tarkington LG, Halperin JL, Yancy CW
ACCF/AHA/HRS. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
J Am Coll Cardiol. 2011;57:223-242. Factor de Impacto: 12.640

Wann LS, Curtis AB, January CT, Ellenbogen KA, Lowe JE, Estes NA 3rd, Page RL, Ezekowitz MD, Slotwiner DJ, Jackman WM, Stevenson WG, Tracy CM; 2006 WRITING COMMITTEE MEMBERS, Fuster V, Rydén LE, Cannom DS, Le Heuzey JY, Crijns HJ, Lowe JE, Curtis AB, Olsson SB, Ellenbogen KA, Prystowsky EN, Halperin JL, Tamargo JL, Kay GN, Wann LS; ACCF/AHA TASK FORCE MEMBERS, Jacobs AK, Anderson JL, Albert N, Hochman JS, Buller CE, Kushner FG, Creager MA, Ohman EM, Ettinger SM, Stevenson WG, Guyton RA, Tarkington LG, Halperin JL, Yancy CW.
ACCF/AHA Task Force Members.
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
Circulation. 2011;123:104-23. Factor de Impacto: 14.816

Fuster V, Rydén LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS.
2011 ACCF/AHA/HRS Focused Updates Incorporated Into the ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial Fibrillation A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
J Am Coll Cardiol. 2011;57:e101-198. Factor de Impacto: 12.640

Gómez-Guzmán M, Jiménez R, Sánchez M, Romero M, O'Valle F, Lopez-Sepulveda R, Quintela AM, Galindo P, Zarzuelo MJ, Bailón E, Delpón E, Perez-Vizcaino F, Duarte J.
Chronic ( - )-epicatechin improves vascular oxidative and inflammatory status but not hypertension in chronic nitric oxide-deficient rats.
Br J Nutr. 2011; 13:1-12.

Barana A, Amorós I, Caballero R, Gómez R, Osuna L, Lillo MP, Blázquez C, Guzmán M, Delpón E, Tamargo J.
Endocannabinoids and cannabinoid analogues block cardiac hKv1.5 channels in a cannabinoid receptor-independent manner.
Cardiovasc Res. 2010;85:56-67.

Amorós I, Barana A, Caballero R, Gómez R, Osuna L, Lillo MP, Tamargo J, Delpón E.
Endocannabinoids and cannabinoid analogues block human cardiac Kv4.3 channnels in a receptor-independent manner.
J Mol Cell Cardiol 2010;85:56-67 .

Tamargo J, Amorós I, Barana A, Caballero R, Delpón E.
New investigational drugs for the management of acute heart failure syndromes.
Current Med Chem 2010;17:363-390.

Tamargo J, Duarte J, Caballero R, Delpón E.
Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure.
Curr Opin Investig Drugs 2010;11:1039-47.

Romero M, Jiménez R, Hurtado B, Moreno JM, Rodríguez-Gómez I, López-Sepúlveda R, Zarzuelo A, Pérez-Vizcaino F, Tamargo J, Vargas F, Duarte J.
Lack of beneficial metabolic effects of quercetin in adult spontaneously hypertensive rats.
Eur J Pharmacol 2010;627:242-50.

Modrego J, Maroto L, Tamargo J, Azcona L, Mateos-Cáceres P, Segura A, Moreno-Herrero R, Pérez-Castellanos N, Delpón E, Pérez-Villacastín J, Rodríguez E, Macaya C, López-Farré AJ.
Comparative expression of proteins in left and right atrial appendages from patients with mitral valve disease at sinus rhythm and atrial fibrillation.
J Cardiovasc Electrophysiol. 2010;21:859-68.

López Farré AJ, Tamargo J, Mateos-Cáceres PJ, Azcona L, Macaya C.
Old and New Molecular Mechanisms Associated with Platelet Resistance to Antithrombotics.
Pharm Res. 2010;27:2365-73.

Prystowsky EN, Camm J, Lip GYH, Allessie M, Bergmann JF, Breithardt G, Brugada J, Crijns H, Ellionor PT, Mark D, Naccarelli G, Packer D, Tamargo J.
The impact of new and emerging clinical data on treatment strategies for atrial fibrillation.
J Cardiovasc Electrophysiol 2010;21:946-958.

Tamargo J, Caballero R, Gómez R, Delpón E.
Cardiac electrophysiological effects of nitric oxide.
Cardiovasc Res. 2010;87:593-600.

Romero M, Jiménez R, Sánchez M, López-Sepúlveda R, Zarzuelo A, Tamargo J, Pérez-Vizcaíno F, Duarte J.
Vascular superoxide production by endothelin-1 requires Src non-receptor protein tyrosine kinase and MAPK activation.
Atherosclerosis. 2010;212:78-85.

Caballero R, González de la Fuente M ; Gómez R, Barana A, Amorós I, Osuna L, Dolz-Gaitón P, Almendral J, Atienza F, Fernández-Avilés F, Pita A, Jorge Rodríguez-Roda J, Pinto A, Tamargo J, Delpón E.
In humans chronic atrial fibrillation decreases I to1 and I Kur differentially on each atria and increases I Ks in both.
J Am Coll Cardiol 2010 ;55:2346-2354.

Caballero R, Dolz-Gaitón P, Gómez R, Amorós I, Barana A, González de la Fuente M , Osuna L, Duarte J, López-Izquierdo A, Moraleda I, Gálvez E, Sánchez-Chapula JA, Tamargo J, Delpón E.
Flecainide increases Kir2.1 currents by interacting with Cysteine-311 decreasing the polyamine-induced rectification.
Proc Natl Acad Sci U S A 2010;107:15631-15636.

Burashnikov E, Pfeiffer R, Barajas-Martinez H, Delpón E, Hu D, Desai M, Borggrefe M, Häissaguerre M, Kanter R, Pollevick Gd, Guerchicoff A, Laiño R, Marieb M, Nademanee K, Nam Gb, Robles R, Schimpf R, Stapleton Dd, Viskin S, Winters S, Wolpert C, Zimmern S, Veltmann C, Antzelevitch C.
Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death.
Heart Rhythm. 2010; 7:1872-1882

Barrios V, Navarro A, Esteras A, Luque M, Romero J, Tamargo J, Prieto L, Carrasco JL, Herranz I, Navarro-Cid J, Ruilope LM
Antihypertensive efficacy and tolerability oflercanidipine in daily clinical practice. The ELYPSE Study
Russian Journal of Cardiology 2010;4:72-77

 

 

 

---

Publicaciones anteriores:

---

1. Cogolludo A, Moreno L, Boscá L, Tamargo J, Pérez-Vizcaíno F. Thromboxane A₂-induced inhibition of voltage-gated K⁺ channels and pulmonary vasoconstriction. Role of protein kinase Cx. Circ Res 2003;93: 656-663.
2. Tamargo J, Caballero R, Delpón E. Phamacological approach in the treatment of atrial fibrillation. Curr Med Chem 2004;11:13-28.
3. López-López G, Moreno L, Cogolludo A, Galisteo M, Ibarra M, Duarte J, Lodi F, Tamargo J, Pérez-Vizcaíno F. Nitric oxide (NO) scavenging and NO protecting effects of quercetin and its biological significance in vascular smooth muscle. Mol Pharmacol 2004;65:851-859.
4. Caballero R, Gómez R, Moreno I, Núñez L, González T, Arias C, Guizy M, Valenzuela C, Tamargo J, Delpón E. Interaction of angiotensin II with the type 2 receptor inhibits the transient outward potassium current. Cardiovasc Res 2004;62: 86-95.
5. Tamargo J, Caballero R, Gómez R, Valenzuela C, Delpón E. Pharmacology of potassium channels. Cardiovasc Res 2004;62:9-33.
6. Pourrier M, Herrera D, Caballero R, Schram G, Wang Z, Nattel S. The Kv4.2 N-terminal restores fast inactivation and confers KChIP2 modulatory effects on N-terminal-deleted Kv1.4 channels. Pflugers Arch. 2004;449:235-247.
7. Banegas JR, Segura J, Ruilope LM, Luque M, García-Robles R, Campo C, Rodríguez-Artalejo F, Tamargo J, on behalf of the CLUE Study Group Investigators. Blood pressure control and physician management of hypertension in hospital hypertension units in Spain. Hypertension 2004;43:1338-1344.
8. López-Sendón J, Swedberg K, MacMurray J, Tamargo J, Maggioni AP, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Expert Consensus Document on b-adrenergic receptor blockers: The Task Force on beta-blockers of the European Society of Cardiology. Eur Heart J 2004;25:1341-1362.
9. López-Sendón J, Swedberg K, Macmurray J, Tamargo J, Maggioni A, Dargy H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Expert Consensus Document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology. Eur Heart J 2004;25:1454-1470.
10. Moreno L, Losada B, Cogolludo AL, Lodi F, Lugnier C, Villamor E, Moro M, Tamargo J, Pérez-Vizcaíno F. Postnatal maturation of phosphodiesterase 5 (PDE5) in piglet pulmonary arteries: activity, expression, effects of PDE5 inhibitors, and role of the nitric oxide/cyclic GMP pathway. Pediatr Res 2004;56:563-570.
11. Caballero R, Gómez R, Núñez L, Moreno I, Tamargo J, Delpón E. Diltiazem inhibits hKv1.5 and Kv4.3 currents at therapeutic concentrations. Cardiovasc Res 2004;64:457-466.
12. López-Sendón J, Swedberg K, MacMurray J, Tamargo J, Maggioni A, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Documento de consenso de expertos sobre el uso de inhibidores de la enzima de conversión de la angiotensina en la enfermedad cardiovascular. Rev Esp Cardiol 2004;57:1213-1232.
13. López-Sendón J, Tamargo J. Bases y evidencias clínicas de los efectos de los nuevos tratamientos farmacológicos en la insuficiencia cardíaca. Rev Esp Cardiol 2004;57:447-464.
14. López-Sendón J, Swedberg K, MacMurray J, Tamargo J, Maggioni A, Dargie H, Tendera M, Waagstein F, Kjekshus J, Lechat P, Torp-Pedersen C. Grupo de trabajo sobre Bloqueadores Beta de la Sociedad Europea de Cardiología. Documento de consenso de expertos sobre bloqueadores de los receptores b-adrenérgicos. Rev Esp Cardiol 2005;58:65-90.
15. Ruilope LM, Tamargo J. Effectiveness and safety of calcium antagonists in hypertensive patients. Med Clin (Barc) 2005;125:412-414.
16. Moreno L, González-Luis G, Cogolludo A, Lodi F, López-Farré A, Tamargo J, Villamor E, Pérez-Vizcaíno F. Soluble guanylyl cyclase during postnatal porcine pulmonary maturation. Am J Physiol 2005;288:L125-L130.
17. Delpón E, Caballero R, Gómez R, Núñez L, Tamargo J. Angiotensin II, angiotensin II antagonists and spironolactone and their modulation of cardiac repolarization. Trends Pharmacol Sci 2005;26:155-161.
18. Cogolludo A, Moreno L, Lodi F, Tamargo J, Pérez-Vizcaíno F. Postnatal maturational shift from PKCz and voltage-gated K⁺ channels to RhoA/Rho kinase in pulmonary vasoconstriction. Cardiovasc Res 2005;66:84-93.
19. Cogolludo A, Pérez-Vizcaíno F, Tamargo J. New insights in the pharmacological therapy of arterial hypertension. Curr Opinion Nephrol Hypertens 2005;14:423-427.
20. Gómez R, Núñez L, Caballero R, Vaquero M, Tamargo J, Delpón E. Spironolactone and its main metabolite canrenoic acid, block hKv1.5, Kv4.3 and Kv7.1 + minK channels. Br J Pharmacol 2005;146:146-161.
21. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for the Management of patients with Atrial Fibrillation A Report of the AmericanCollege of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:651-745.
22. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death - A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol 2006;48:e247-346.
23. Alonso-Orgaz S, Moreno L, Macaya C, Rico L, Mateos-Caceres PJ, Sacristan D, Perez-Vizcaino F, Segura A, Tamargo J, Lopez-Farre A. Proteomic study of plasma from moderate hypercholesterolemic patients. J Proteome Res 2006;5:2301-2308.
24. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385-484.
25. Zipes DP Co-Chair, Camm AJ Co-Chair, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Smith SC Jr Chair, Jacobs AK Vice-Chair, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG Chair, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac DeathA Report of the American College of Cardiology/AmericanHeart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines Developed in Collaboration With the European Heart Rhythm Association and the Heart Rhythm Society. Europace 2006;8:746-837.
26. Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, Gregoratos G, Klein G, Moss AJ, Myerburg RJ, Priori SG, Quinones MA, Roden DM, Silka MJ, Tracy C, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC Jr, Jacobs AK, Adams CD, Antman EM, Anderson JL, Hunt SA, Halperin JL, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death--executive summary: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Eur Heart J 2006;27:2099-2140.
27. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines: developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-354.
28. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol 2006;48:854-906.
29. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S; Task Force on Practice Guidelines, American College of Cardiology/American Heart Association. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines. Eur Heart J 2006;27:1979-2030.
30. Nuñez L, Vaquero M, Gomez R, Caballero R, Mateos-Caceres P, Macaya C, Iriepa I, Galvez E, Lopez-Farre A, Tamargo J, Delpon E. Nitric oxide blocks hKv1.5 channels by S-nitrosylation and by a cyclic GMP-dependent mechanism. Cardiovasc Res 2006;72:80-89.
31. Lodi F, Cogolludo A, Duarte J, Moreno L, Coviello A, Peral de Bruno M, Vera R, Galisteo M, Tamargo J, Pérez-Vizcaino F. Increased NADPH oxidase activity mediates spontaneous aortic tone in genetically hypertensive rats. Eur J Pharmacol 2006;544:97-103.
32. Fox K, Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Zamorano JL, Andreotti F, Becher H, Dietz R, Fraser A, Gray H, Antolin RA, Huber K, Kremastinos DT, Maseri A, Nesser HJ, Pasierski T, Sigwart U, Tubaro M, Weis M. Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. Eur Heart J 2006;27:1341-1381.
33. Tamargo J, Delpón E, Caballero R. The safety of digoxin as a pharmacological treatment of atrial fibrillation. Expert Opin Drug Saf 2006;5:453-467.
34. González-Luis G, Cogolludo A, Moreno L, Lodi F, Tamargo J, Pérez-Vizcaino F, Villamor E. Relaxant effects of the soluble guanylate cyclase activator and NO sensitizer YC-1 in piglet pulmonary arteries. Biol Neonate 2006;90:66-72.
35. Cogolludo A, Moreno L, Lodi F, Frazziano G, Cobeño L, Tamargo J, Pérez-Vizcaino F. Serotonin inhibits voltage-gated K⁺ currents in pulmonary artery smooth muscle cells. Role of 5-HT2A receptors, caveolin-1, and Kv1.5 channel internalization. Circ Res 2006;98:931-938.
36. Sánchez M, Galisteo M, Vera R, Villar IC, Zarzuelo A, Tamargo J, Pérez-Vizcaino F, Duarte J. Quercetin downregulates NADPH oxidase, increases eNOS activity and prevents endothelial dysfunction in spontaneously hypertensive rats. J Hypertens 2006;24:75-84.
37. Tutor AS, Delpon E, Caballero R, Gomez R, Nunez L, Vaquero M, Tamargo J, Mayor F Jr, Penela P. Association of 14-3-3 Proteins to b1-Adrenergic Receptors Modulates Kv11.1 K⁺ Channel Activity in Recombinant Systems. Mol Biol Cell 2006;17:4666-4674.
38. Fox K, Alonso Garcia MA, Ardissino D, Buszman P, Camici PG, Crea F, Daly C, De Backer G, Hjemdahl P, Lopez-Sendon J, Marco J, Morais J, Pepper J, Sechtem U, Simoons M, Thygesen K, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Osterspey A, Tamargo J, Zamorano JL, Andreotti F, Becher H, Dietz R, Fraser A, Gray H, Hernandez Antolin RA, Huber K, Kremastinos DT, Maseri A, Nesser HJ, Pasierski T, Sigwart U, Tubaro M, Weis M. Guidelines on the management of stable angina pectoris: executive summary. Task Force per il Trattamento dell'Angina Pectoris Stabile della Societa Europea di Cardiologia. G Ital Cardiol 2006;7:535-583.
39. Fuster V, Lyden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Key N, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S. Kardiol Pol. Guidelines on the management of stable angina pectoris: executive summary. 2006;64:1223-1280.
40. Cogolludo A, Frazziano G, Cobeño L, Moreno L, Lodi F, Villamor E, Tamarg J, Pérez-Vizcaino F. Role of reactive oxygen species in Kv channel inhibition and vasoconstriction induced by TP receptor activation in rat pulmonary arteries. Ann N Y Acad Sci 2006;1091:41-51.
41. Marín R, De la Sierra A, Armario P, Campo C, Banegas JR, Gorostidi M, en representación de la Sociedad Española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA). Guía sobre el diagnóstico y tratamiento de la hipertensión arterial en España 2005. Med Clin (Barc) 2005;125 (Nº 1):24-34.
42. Tamargo J, Caballero R, Gómez R, Núñez L, Vaquero M, Delpón E. Efectos del oxido nitrico sobre la función cardiaca. Rev Esp Cardiol 2006;6 (Supl A):3A-20A.
43. Tamargo J. Farmacología clínica de los calcioantagonistas. Potenciales diferencias basadas en la duración de acción y tipo de formulación. Hipertensión 2006; 23 (Nº Extraordinario):3-12.
44. Núñez L, Caballero R, Gómez R, Vaquero M, Delpón E, Tamargo J. Mecanismo de acción de la eplerenona. Rev Esp Cardiol 2006;6 (Supl B):31B-47B.
45. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Neal Kay G, Lowe JE, Bertil Olsson S, Prystowsky EN, Tamargo JL, Wann S. Guidelines for the Management of Patients With Atrial Fibrillation. Executive Summary. Rev Esp Cardiol. 2006;59:1329.e1-64.
46. Tamargo J, Caballero R, Gómez R, Núñez L, Vaquero M, Delpón E. Características farmacológicas de los ARA II ¿Son todos iguales?. Rev Esp Cardiol 2006;6 (Supl C):10C-24C.
47. Caballero R, Gómez R, Núñez L, Vaquero M, Tamargo J, Delpón E. Farmacología de los ácidos grasos omega-3. Rev Esp Cardiol 2006;6 (Supl D):3D-19D.
48. Vaquero M, Gómez R, Núñez L, Caballero R, Delpón E, Barana A y Tamargo J. Ivabradina, un bloqueador selectivo de la corriente If. Aspectos farmacológicos y tolerabilidad. Rev Esp Cardiol 2007;7 (Supl.):32D-45D.
49. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A; Grupo de Trabajo sobre el Tratamiento de las Valvulopatias de la Sociedad Europea de Cardiologia. Guía de práctica clínica sobre el tratamiento de las valvulopatías. Rev Esp Cardiol. 2007;60:625.e1-e50.
50. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosion E, Fagard R, Lindholm LH, Manolis A, Nilsson PM, Redon J, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Bertomeu V, Clement D, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL. ESH/ESC 2007 Guidelines for the management of arterial hypertension. Rev Esp Cardiol. 2007;60:968.e1-94.
51. Ryden L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jonsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyorala K, Raz I, Schernthaner G, Volpe M, Wood D. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary: The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007;28:88-136.
52. Tamargo J, Caballero R, Núñez L, Gómez R, Vaquero M, Delpón E. Genetically engineered mice as a model for studying cardiac arrhythmias. Front Biosci 2007;12:22-38.
53. Cogolludo A, Frazziano G, Briones AM, Cobeño L, Moreno L, Lodi F, Salaices M, Tamargo J, Perez-Vizcaino F. The dietary flavonoid quercetin activates BKCa currents in coronary arteries via production of H₂O₂. Role in vasodilatation. Cardiovasc Res 2007;73:424-431.
54. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Zamorano JL, Angelini A, Antunes M, Fernandez MA, Gohlke-Baerwolf C, Habib G, McMurray J, Otto C, Pierard L, Pomar JL, Prendergast B, Rosenhek R, Uva MS, Tamargo J. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J. 2007;28:230-268.
55. Sánchez M, Lodi F, Vera R, Villar IC, Cogolludo A, Jimenez R, Moreno L, Romero M, Tamargo J, Pérez-Vizcaino F, Duarte J. Quercetin and isorhamnetin prevent endothelial dysfunction, superoxide roduction and overexpression of p47^phox induced by angiotensin II in rat aorta. J Nutrition 2007;137:910-915.
56. Tamargo J, Caballero R, Gómez R, Núñez L, Vaquero M, Delpón E. Lipid-lowering therapy with statins, a new approach to antiarrhythmic therapy. Pharmacol Ther 2007; 114:107-126.
57. Vaquero M, Caballero R, Gomez R, Nunez L, Tamargo J, Delpon E. Effects of atorvastatin and simvastatin on atrial plateau currents. J Mol Cell Cardiol 2007;42:931-945.
58. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo JL, Zamorano JL, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Halperin JL, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA/ESC 2006 Orientações de 2006 da ACC/AHA/ESC para o tratamento de doentes com fibrilhaçaõ auricular. Relatório do grupo de trabalho da American College of Cardiology/American Heart Association sobre orientações da European Society of Cardiology para orientações prácticas (Comissão de Redacãço para a revisão das Orientações de 2001 relativas ao Tratamento de Doentes com Fibrilhação Auricular). Rev Port Cardiol 2007;26:383-446.
59. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B; 2007 ESH-ESC guidelines for the management of arterial hypertension - The task force for the management of arterial hypertension of the European society of hypertension (ESH) and of the European society of cardiology (ESC). Blood Pressure 2007;16:135-232.
60. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Erdine S, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Lindholm LH, Viigimaa M, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Waeber B, Williams B; Management of Arterial Hypertension of the European Society of Hypertension; European Society of Cardiology. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007;25:1105-1187.
61. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A; ESC Committee for Practice Guidelines (CPG):, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL; ESH Scientific Council:, Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M; Document Reviewers:, Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 2007;28:1462-1536.
62. Rydén L Standl E, Bartnik M, Van den Berghe G, Betteridge J, De Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Östergren J, Tuomilehto J, Thrainsdottir I, Other contributors, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, ESC Committee for Practice Guidelines (CPG), Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterpey A, Tamargo J, Zamorano JL. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: full text. The Task Force on Diabetes and Cardiovascular Diseases if the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J Supplements 2007;9 (suppl. C):C3-C74.
63. Moreno L, Frazziano G, Cogolludo A, Cobeno L, Tamargo J, Perez-Vizcaino F. Role of Protein Kinase Cx and its Adaptor Protein p62 in Voltage-Gated Potassium Channel Modulation in Pulmonary Arteries. Mol Pharmacol 2007;72:1301-1309.
64. Grupo de Trabalho da American College of Cardiology/American Heart Association sobre orientações prácticas e da comissão da European Society of Cardiology para orientações práctcicas. [ACC/AHA/ESC 2006 guidelines for the management of patients with ventriculr arrhythmias and the prevention of sudden cardiac death—executive summary]. Rev Port Cardiol 2007;26:883-937.
65. Radicke S, Vaquero M, Caballero R, Gómez R, Núñez L, Tamargo J, Ravens U, Wettwer E, Delpon E. Effect of MiRP1 and DPP6 beta-subunits on the blockade induced by flecainide of Kv4.3/KChIP2 channels. Brit J Pharmacol 2008;154:774-786.
66. Delpón E, Cordeiro Jm, Núñez L, Bloch Thomsen Pe, Guerchicoff A, Pollevick G, Wu Y, Kanters Jk, Larsen Kt, Christiansen M, Antzelevitch C. Functional effects of KCNE3 mutation and its role in the development of Brugada Syndrome. Circulation (arrhythmia and electrophysiology). 2008; 1: 209-218
67. Tamargo, J. New Drugs for Acute Heart Failure. Methods Find Exp Clin Pharmacol 2008; 30 (Suppl.2): 13-15.
68. Sacristán D, Marques M, Zamorano-Leon JJ, Luque M; Armengol J, del Castillo J, Martin J, Delpón E, Ramos-Mozo P, de Prada TP, Tamargo J, Barrientos A, Macaya C, Lopez-Farre A. Modifications by Olmesartan medoxomil treatment of the platelet protein profile of moderate hypertensive patients. Proteomics Clin Appl 2008;2:1300-1312.
69. Tamargo J, López-Sendón JL. Digitalis: A dangerous drug in atrial fibrillation?. An análisis of the SPORTIF III and V data. Southern Med J 2008;94:191-196.
70. Gómez R, Núñez L, Vaquero M, Amorós I, Barana A, de Prada T, Macaya C, Maroto L, Rodríguez E, Caballero R, López-Farré A, Tamargo J, Delpón E. Nitric oxide inhibits Kv4.3 and human cardiac transient outward potassium current (I_to1). Cardiovasc Res 2008;80:375-84.
71. de la Sierra A, Gorostidi M, Marín R, Redón J, Banegas JR, Armario P, García Puig J, Zarco J, Llisterri JL, Sanchís C, Abarca B, Palomo V, Gomis R, Otero A, Villar F, Honorato J, Tamargo J, Lobos JM, Macías-Núñez J, Sarría A, Aranda P, Ruilope LM. Evaluation and management of hypertension in Spain. A consensus guide. Med Clin (Barc) 2008;131:104-116.
72. Marrugat J, López-Sendón JR, Heras M, Tamargo J, Valverde M; Comité Ejecutivo de la Red HERACLES. The HERACLES Cardiovascular Network. Rev Esp Cardiol 2008;61:66-76.
73. Tamargo J. Combinación de fármacos antihipertensivos: situación actual. Med Clin 2009;10:8-11.
74. Tamargo J, Gómez R, Amorós I, Barana A, Caballero R, Delpón E. Fisiopatología de la prorrenina y la renina. Cincuenta años en busca de los inhibidores directos de la renina. Sus ventajas y sus limitaciones. Rev Esp Cardiol 2009;9(Supl A):24-40.
75. Tamargo J, Delpón E. Estimulación vagal y remodelado eléctrico auricular.Rev Esp Cardiol 2009;62:729-732.
76. Tamargo J, Caballero R, Gómez R, Barana A, Amoros I, Delpón E. Investigational positive inotropic agents for acute heart failure. Cardiovasc Haematol disorders-Drug Target 2009;9:193-205.
77. Gómez R, Caballero R, Barana A, Amoros I, Calvo E, López JA, Klein H, Vaquero M, Osuna L, Atienza F, Almendral J, Pinto A, Tamargo J, Delpón E. Nitric oxide increasescardiac I_K1 by nitrosylation of cysteine 76 of Kir2.1 channels. Circ Res 2009;105:383-392.
78. Tamargo J, Delpón E. Vagal stimulation and atrial electrical remodeling. Rev Esp Cardiol 2009;62:729-32.
79. Tamargo J, Caballero R, Gómez R, Delpón E. IK_ur/Kv1.5 channel blockers for the treatment of atrial fibrillation. Expert Opin Investig Drugs 2009;18:399-416.
80. Tamargo J, López-Farre A, Caballero R, Delpon E. Omecamtiv mecarbil (CK-1827452), a cardiac myosin activator for heart failure. Drugs Future 2009;34:950-961.